Tower Research Capital LLC (Trc) Enlivex Therapeutics Ltd. Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$4.92 - $6.66 $319 - $432	-65 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.81 - $9.73 $703 - $1,177	-121 Reduced 65.05%	65 $0
Q3 2021 Nov 15, 2021	BUY	$7.43 - $13.86 $1,381 - $2,577	186 New	186 $2,000
Q2 2021 Aug 16, 2021	SELL	$8.61 - $12.1 $21,430 - $30,116	-2,489 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.26 - $24.0 $23,048 - $59,736	2,489 New	2,489 $28,000

2.58M

20.8K

Ticker ENLV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,403,200
Market Cap $23M
Description
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.